🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
TTP is a rare and serious blood disorder, characterized by the formation of...
Status
Completed
Location
St Bartholomew's Hospital
Start Date
2006-03
Trial ID
NCT00937131
Treatments Being Tested
This is an open-label Phase I/II trial to assess the feasibility and safety...
Status
Completed
Location
University of Pittsburgh Medical Center
Start Date
2011-03
Trial ID
NCT01266317
Treatments Being Tested
This trial evaluates the addition of rituximab to standard of care in the t...
Status
Terminated
Location
Imperial College London
Start Date
2019-07-17
Trial ID
NCT03994783
Treatments Being Tested
Immune thrombotic thrombocytopenic purpura (iTTP) is caused by a severe, au...
Status
Recruiting
Location
Chu Amiens
Start Date
2024-04-10
Trial ID
NCT06291025
Treatments Being Tested
This is a study of TAK-755 in adults with immune-mediated thrombotic thromb...
Status
Completed
Location
University of Florida - Shands
Start Date
2023-07-21
Trial ID
NCT05714969
Treatments Being Tested
This research involves the use of immune base therapy as an adjunct to plas...
Status
Completed
Location
Ohio State University
Start Date
2007-11
Trial ID
NCT00713193
Treatments Being Tested
Retrospective evaluation of the value of additive therapeutic plasma exchan...
Status
Completed
Location
University Hospital Aachen (RWTH)
Start Date
2024-01-01
Trial ID
NCT06187220
Treatments Being Tested
This is a randomized, multi-center, open-label Phase II clinical trial to d...
Status
Withdrawn
Location
Geisinger Medical Center
Start Date
2012-09
Trial ID
NCT01524068
Treatments Being Tested